poLight ASA (the "Company") has a general share option scheme, whereby share
options in the Company are granted to all employees.
The Company has received notices of exercise of 777 share options, 444 of the
share options hold an exercise price of NOK 50 per option, 222 of the share
options hold an exercise price of NOK 33.75 and 111 of the share options hold an
exercise price of NOK 27.
The Board of Directors has today resolved a share capital increase of NOK 155.40
through issuance of 777 new shares in order to satisfy the Company's obligation
to deliver shares following exercise of share options. The new shares have been
issued based on an authorization to increase the share capital granted to the
Board of Directors on 26 May 2021.
Further information from:
Øyvind Isaksen, CEO, poLight ASA: +47 90 87 63 98
About poLight ASA
poLight offers a new autofocus lens which "replicates" the human eye for use in
devices such as smartphones, wearables, barcode, machine vision systems and
various medical equipment. poLight's TLens enables better system performance and
new user experiences due to benefits such as extremely fast focus, small
footprint, no magnetic interference, low power consumption and constant field of
view. poLight is based in Horten, Norway, with offices in Finland and China and
representation in France, UK, US, Taiwan, Korea and Japan. For more information,
please visit https://www.polight.com